A Danish biopharmaceutical company focused on developing and commercializing treatments for brain diseases, including depression, schizophrenia, Parkinson’s disease, and migraine. Its portfolio includes several central nervous system therapies marketed globally, alongside a pipeline of neurology and...
No congressional trades have been disclosed for H. Lundbeck A/S (HLUYY) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.